We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+14.01%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$5.65B
AUM Growth
+$653M
Cap. Flow
-$1.9M
Cap. Flow %
-0.03%
Top 10 Hldgs %
20.22%
Holding
216
New
2
Increased
42
Reduced
67
Closed
3

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$46M
2
TTD icon
Trade Desk
TTD
+$22.5M
3
MCD icon
McDonald's
MCD
+$10.8M
4
AMZN icon
Amazon
AMZN
+$7.49M
5
DXCM icon
DexCom
DXCM
+$6.92M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$42.1M
2
ADBE icon
Adobe
ADBE
+$21.2M
3
CRWD icon
CrowdStrike
CRWD
+$15.3M
4
SNPS icon
Synopsys
SNPS
+$8.67M
5
WDAY icon
Workday
WDAY
+$8.16M

Sector Composition

Rank Sector Weight
1 Technology 32.45%
2 Healthcare 16.85%
3 Consumer Discretionary 13.12%
4 Industrials 12.39%
5 Financials 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LHX icon
76
L3Harris
LHX
$55.4B
$20.9M 0.37%
99,235
+28,360
+40% +$5.32M
STVN icon
77
Stevanato
STVN
$5.57B
$20.7M 0.37%
757,094
-55
-0% -$1.58K
BJ icon
78
BJs Wholesale Club
BJ
$12.8B
$20.1M 0.36%
301,806
– –
IQV icon
79
IQVIA
IQV
$40.7B
$19.9M 0.35%
86,001
-10
-0% -$2.05K
LII icon
80
Lennox International
LII
$15B
$19.9M 0.35%
44,440
-2,425
-5% -$967K
RSG icon
81
Republic Services
RSG
$67.4B
$19.7M 0.35%
119,440
-6,545
-5% -$1.02M
GMED icon
82
Globus Medical
GMED
$11.1B
$19.5M 0.34%
365,521
+4,855
+1% +$237K
CPAY icon
83
Corpay
CPAY
$25.7B
$19.3M 0.34%
68,345
-10
-0% -$2.48K
TRU icon
84
TransUnion
TRU
$16B
$19.1M 0.34%
278,205
+29,265
+12% +$1.78M
BR icon
85
Broadridge
BR
$18.4B
$19.1M 0.34%
92,885
-10
-0% -$1.84K
ESTC icon
86
Elastic
ESTC
$6.7B
$18.9M 0.33%
167,400
-18,490
-10% -$1.64M
STE icon
87
Steris
STE
$22.9B
$18.8M 0.33%
85,485
-10
-0% -$2.12K
ODFL icon
88
Old Dominion Freight Line
ODFL
$46.3B
$18.7M 0.33%
92,030
-10
-0% -$1.98K
TECH icon
89
Bio-Techne
TECH
$11.2B
$18M 0.32%
232,859
+64,250
+38% +$4.23M
SCI icon
90
Service Corp International
SCI
$11.8B
$17.8M 0.32%
260,135
– –
ATR icon
91
AptarGroup
ATR
$8.69B
$17.5M 0.31%
141,850
-255
-0.2% -$32.1K
OKTA icon
92
Okta
OKTA
$23.8B
$17.4M 0.31%
191,712
-21,290
-10% -$1.62M
MTD icon
93
Mettler-Toledo International
MTD
$28.1B
$16.8M 0.3%
13,850
+920
+7% +$995K
CRL icon
94
Charles River Laboratories
CRL
$11.3B
$16.7M 0.3%
70,681
+10,695
+18% +$2.1M
COO icon
95
Cooper Companies
COO
$14.2B
$16.6M 0.29%
174,960
– –
NTRS icon
96
Northern Trust
NTRS
$21.8B
$15.8M 0.28%
187,785
– –
PCTY icon
97
Paylocity
PCTY
$7.75B
$15.8M 0.28%
95,625
-1,525
-2% -$257K
IEX icon
98
IDEX
IEX
$17B
$15.6M 0.28%
71,830
– –
VEEV icon
99
Veeva Systems
VEEV
$33.8B
$15.5M 0.27%
80,600
+5,905
+8% +$1.11M
TDY icon
100
Teledyne Technologies
TDY
$29.2B
$15.3M 0.27%
34,225
+2,535
+8% +$1.02M
2 3
4
5 6

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q4 2023 Portfolio in Review

As of Q4 2023, Nicholas Company held 216 positions worth $5.65B, up 13% from $5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. Nicholas Company opened 2 new positions and exited 3, leaving the 216-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nicholas Company's largest Q4 2023 buy was Pfizer: 224,525 shares worth $6.46M.
  • Nicholas Company added most to AstraZeneca in Q4 2023, an estimated $46M increase.
  • Nicholas Company's biggest Q4 2023 reduction was Johnson & Johnson, cutting an estimated $42.1M.
  • Nicholas Company fully exited Fidelity National Information Services in Q4 2023, selling an estimated $7.55M.
  • Nicholas Company's ten largest holdings make up 20% of its $5.65B portfolio in Q4 2023.
  • Nicholas Company opened 2 new positions and closed 3 in Q4 2023.
  • Nicholas Company's portfolio value rose 13% quarter-over-quarter to $5.65B.

Based on Nicholas Company's 13F filing for Q4 2023, filed 13 Feb 2024.